Maxline Pet Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in Nagpur, Maharashtra, India, established in 2023.
2023 Nagpur, Maharashtra, India Active
Last Updated:
About Maxline Pet Pharmaceuticals Private Limited

Maxline Pet Pharmaceuticals Private Limited, a active private limited company, was established on 13 April 2023 in Nagpur, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21005MH2023PTC400835. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹0.10 M.

Its leadership includes Abdul Soyeb Abdul Gaffar (Director), Anees Ahmad (Director). It is based at House No 3171-A-72, Azad Coloney, Nagpur, Maharashtra, 440024.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21005MH2023PTC400835

  • Registration Number

    400835

  • Incorporation Date

    13 April 2023

  • Authorized Capital

    ₹0.40 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.40 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 9 Months
Company report

Maxline Pet Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Maxline Pet Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Maxline Pet Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Abdul Soyeb Abdul Gaffar Director 13 Apr 2023 Current
Anees Ahmad Director 13 Apr 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maxline Pet Pharmaceuticals.

Enhance accessibility to Maxline Pet Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Maxline Pet Pharmaceuticals revenue growth over time
Maxline Pet Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maxline Pet Pharmaceuticals?

Unlock access to Maxline Pet Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Maxline Pet Pharmaceuticals?

Unlock and access historical data on people associated with Maxline Pet Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maxline Pet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxline Pet Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maxline Pet Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Abdul Soyeb Abdul Gaffar was appointed as a Director was appointed as a Director on 13 Apr 2023 & has been associated with this company since 2 years 9 months . was documented.

  • Director Appointment

    The activity Anees Ahmad was appointed as a Director was appointed as a Director on 13 Apr 2023 & has been associated with this company since 2 years 9 months . was completed.

  • Company Incorporation

    Progress on Maxline Pet Pharmaceuticals Private Limited was registered on 13 Apr 2023 with Roc Mumbai & aged 2 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maxline Pet Pharmaceuticals Private Limited?

The CIN of Maxline Pet Pharmaceuticals Private Limited is U21005MH2023PTC400835.

Where is Maxline Pet Pharmaceuticals Private Limited headquartered?

Maxline Pet Pharmaceuticals Private Limited is headquartered at House No 3171-A-72, Azad Coloney, Nagpur, Maharashtra, 440024.

When was Maxline Pet Pharmaceuticals Private Limited incorporated?

Maxline Pet Pharmaceuticals Private Limited was incorporated on 13 April 2023.

Who are the current directors of Maxline Pet Pharmaceuticals Private Limited?

The current directors of Maxline Pet Pharmaceuticals Private Limited are

What is the primary industry of Maxline Pet Pharmaceuticals Private Limited?

The primary industry of Maxline Pet Pharmaceuticals Private Limited is Paper.

Is Maxline Pet Pharmaceuticals Private Limited a listed company?

Maxline Pet Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Maxline Pet Pharmaceuticals Private Limited?

The authorized capital of Maxline Pet Pharmaceuticals Private Limited is ₹0.40 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available